000 | 01080 a2200289 4500 | ||
---|---|---|---|
005 | 20250513235645.0 | ||
264 | 0 | _c20010816 | |
008 | 200108s 0 0 eng d | ||
022 | _a1354-3784 | ||
024 | 7 |
_a10.1517/13543784.10.5.811 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBerman Rosenzweig, E | |
245 | 0 | 0 |
_aNovel therapeutics for the treatment of paediatric pulmonary arterial hypertension. _h[electronic resource] |
260 |
_bExpert opinion on investigational drugs _cMay 2001 |
||
300 |
_a811-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aEndothelin Receptor Antagonists |
650 | 0 | 4 |
_aEndothelin-1 _xphysiology |
650 | 0 | 4 |
_aEpoprostenol _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
700 | 1 | _aBarst, R J | |
773 | 0 |
_tExpert opinion on investigational drugs _gvol. 10 _gno. 5 _gp. 811-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.10.5.811 _zAvailable from publisher's website |
999 |
_c11256924 _d11256924 |